Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in advanced non-squamous NSCLC
NCT00863746Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 34
01
Overview
A Phase 3 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Bayer. Started Apr 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00863746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863746.